Risk factors for metastasis at presentation with conventional chondrosarcoma: a population-based study
- 113 Downloads
The aim of the study was to investigate risk factors for metastasis at diagnosis.
We collected patients diagnosed with conventional chondrosarcoma between 1983 and 2014 from the Surveillance, Epidemiology, and End Results (SEER) database. Each patient was classified as having metastatic or localized disease. Univariate and multivariate logistic regression analyses were applied to determine which characteristics were risk factors for metastasis at diagnosis.
Two thousand three hundred forty-nine patients were collected and 180 patients had metastasis at presentation. Data on age, gender, primary site, grade, and tumour size were enrolled into the multivariate logistic analysis. Greater age (60 years or older: OR = 1.872, 95% CI, 1.206 to 2.904), axial or craniofacial location (spine: OR = 1.775, 95% CI, 1.188 to 2.651; thoracic cage: OR = 2.034, 95% CI, 1.321 to 3.134; craniofacial bones: OR = 5.507, 95% CI, 3.001 to 10.107), higher grade (grade II: OR = 1.849, 95%CI, 1.181 to 2.895; grade III: OR = 4.016, 95%CI, 2.513 to 6.418), and larger tumour size (size over 10 cm: OR = 7.135, 95%CI, 2.130 to 23.893) were associated with an increased risk of metastasis at presentation.
Conventional chondrosarcoma patients with greater age, axial or craniofacial tumour location, higher grade, and larger tumor size were more likely to have metastasis at diagnosis.
KeywordsBone cancer Conventional chondrosarcoma Risk factor Metastasis
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
Because we obtain data from the SEER database with open access, we did not need to acquire patient consent or ethical review committee statement, but we were required to sign a Data-Use Agreement for the SEER 1973–2014 Research Data File to gain access to the SEER database.
- 1.Biermann JS, Chow W, Reed DR, Lucas D, Adkins DR, Agulnik M, Benjamin RS, Brigman B, Budd GT, Curry WT, Didwania A, Fabbri N, Hornicek FJ, Kuechle JB, Lindskog D, Mayerson J, McGarry SV, Million L, Morris CD, Movva S, O'Donnell RJ, Randall RL, Rose P, Santana VM, Satcher RL, Schwartz H, Siegel HJ, Thornton K, Villalobos V, Bergman MA, Scavone JL (2017) NCCN guidelines insights: bone cancer, version 2.2017. J Natl Compr Cancer Netw 15(2):155–167CrossRefGoogle Scholar
- 2.Fletcher CDM, Bridge JA, Hogendoorn P, Mertens F (2013) WHO classification of tumours of soft tissue and bone, vol 5, 4th edn. IARC Press, LyonGoogle Scholar
- 6.van Maldegem AM, Gelderblom H, Palmerini E, Dijkstra SD, Gambarotti M, Ruggieri P, Nout RA, van de Sande MA, Ferrari C, Ferrari S, Bovee JV, Picci P (2014) Outcome of advanced, unresectable conventional central chondrosarcoma. Cancer 120(20):3159–3164. https://doi.org/10.1002/cncr.28845 CrossRefPubMedGoogle Scholar
- 14.Mukherjee D, Chaichana KL, Parker SL, Gokaslan ZL, McGirt MJ (2013) Association of surgical resection and survival in patients with malignant primary osseous spinal neoplasms from the Surveillance, Epidemiology, and End Results (SEER) database. Eur Spine J 22(6):1375–1382. https://doi.org/10.1007/s00586-012-2621-4 CrossRefPubMedGoogle Scholar